13F Portfolios

BlackBarn Capital Partners LP: VIKING THERAPEUTICS INC (VKTX): Quarterly 13F Position History

As of Q1 2026, BlackBarn Capital Partners LP reported 621,450 shares of VIKING THERAPEUTICS INC (VKTX), worth $20.2M and representing 6.1% of its 13F equity book. Quarter-over-quarter share count change: + 71,450 (+13.0%) . The position first appeared in Q2 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 621,450 +71,450 +13.0% $20.2M 6.1% $32.5
Q4 2025 550,000 +50,000 +10.0% $19.3M 6.9% $35.2
Q3 2025 500,000 +150,000 +42.9% $13.1M 4.3% $26.3
Q2 2025 350,000 $9.3M 3.1% $26.5

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did BlackBarn Capital Partners LP first disclose a VKTX position in 13F-HR filings?

BlackBarn Capital Partners LP first reported VIKING THERAPEUTICS INC (VKTX) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.

What was BlackBarn Capital Partners LP's most recent quarter-over-quarter share-count change in VKTX?

Between Q4 2025 and Q1 2026, BlackBarn Capital Partners LP added 71,450 shares of VKTX (+13.0%), bringing the total reported position to 621,450 shares at a market value of $20.2M.

Does the implied price-per-share represent BlackBarn Capital Partners LP's cost basis in VKTX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.